These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Constructing prognostic model incorporating the 2004 WHO/ISUP classification for patients with non-muscle-invasive urothelial tumours of the urinary bladder. Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM J Clin Pathol; 2010 Oct; 63(10):910-5. PubMed ID: 20876324 [TBL] [Abstract][Full Text] [Related]
23. [Importance of endoscopic biopsy in bladder tumors]. Ondrus B; Hornák M; Zvara V Z Urol Nephrol; 1968 Dec; 61(12):843-52. PubMed ID: 5731196 [No Abstract] [Full Text] [Related]
24. The case for conservative management in the treatment of patients with non-muscle-invasive micropapillary bladder carcinoma without carcinoma in situ. Gaya JM; Palou J; Algaba F; Arce J; Rodríguez-Faba O; Villavicencio H Can J Urol; 2010 Oct; 17(5):5370-6. PubMed ID: 20974029 [TBL] [Abstract][Full Text] [Related]
25. Watchful waiting for low-grade Ta bladder tumours: the idea would have been unacceptable 30 years ago, but nowadays we are highly interested in the results of this study exploring it. Oosterlinck W Eur Urol; 2006 Feb; 49(2):215-6. PubMed ID: 16426733 [No Abstract] [Full Text] [Related]
26. BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group. Debruyne FM; van der Meijden AP; Franssen MP Prog Clin Biol Res; 1989; 303():435-46. PubMed ID: 2506556 [No Abstract] [Full Text] [Related]
27. [The evolution of papillary tumors of the bladder. (propos of 107 cases)]. Lakrissa A; Tazi A Maghrib Tibbi; 1981 Dec; 3(4):773-9. PubMed ID: 7348284 [No Abstract] [Full Text] [Related]
34. [Aspiration biopsy in the cytological diagnosis of bladder tumors]. Riedel B; Löhe E; Kelâmi A Urologe; 1970 May; 9(3):133-4. PubMed ID: 5521796 [No Abstract] [Full Text] [Related]
35. Lymphoepithelioma-Like Carcinoma of the Urinary Bladder. Kessler ER; Amini A; Wilson SS; Breaker K; Raben D; La Rosa FG Oncology (Williston Park); 2015 Jun; 29(6):462, C3. PubMed ID: 26089221 [No Abstract] [Full Text] [Related]
36. Treatment of carcinoma of the bladder: a summary. Jewett HJ Proc Natl Cancer Conf; 1970; 6():211-7. PubMed ID: 5458095 [No Abstract] [Full Text] [Related]
37. Effect of intravesical Bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder. Herr HW; Pinsky CM; Whitmore WF; Oettgen HF; Melamed MR Cancer; 1983 Apr; 51(7):1323-6. PubMed ID: 6337700 [No Abstract] [Full Text] [Related]
38. Topical use of Thio-Tepa for tumours of the bladder. Oravisto KJ Urol Int; 1965; 20(1):23-8. PubMed ID: 4953655 [No Abstract] [Full Text] [Related]
39. Concurrent malakoplakia and papillary urothelial carcinoma of the urinary bladder. Darvishian F; Teichberg S; Meyersfield S; Urmacher CD Ann Clin Lab Sci; 2001 Apr; 31(2):147-50. PubMed ID: 11337903 [TBL] [Abstract][Full Text] [Related]
40. New aspects in combined treatment of urinary bladder carcinoma. Albert L; Arndt J; Hienzsch E; Kriester A Eur Urol; 1975; 1(3):117-21. PubMed ID: 1233176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]